Information Provided By:
Fly News Breaks for October 30, 2015
ACRX
Oct 30, 2015 | 07:31 EDT
Jefferies analyst Hugo Ong upgraded AcelRx to Buy with a $7 price target after assuming coverage of the name. The analyst sees a favorable risk/reward with a focus on the company's ARX-04 for acute pain.
News For ACRX From the Last 2 Days
There are no results for your query ACRX